Actively Recruiting
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
Led by Beijing Tiantan Hospital · Updated on 2025-04-13
800
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to establish a multi-center and multi-modality imaging standard cohort of cerebrovascular disease, analyze the potential mechanisms affecting the prognosis of cerebrovascular disease based on a variety of imaging methods, and explore potential therapeutic targets.
CONDITIONS
Official Title
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years old
- Onset of symptoms within 7 days
- Clinical diagnosis of cerebrovascular disease (ischemic or hemorrhagic stroke) confirmed by head imaging (CT or MRI)
- Signed informed consent form
You will not qualify if you...
- Diagnosed with non-cerebrovascular diseases such as central nervous system infections, epilepsy, or metabolic encephalopathy
- Contraindications to multimodal CT, MRI, functional near-infrared imaging, or inability to cooperate with examinations
- Life expectancy less than 3 months or inability to complete study follow-up for other reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070
Actively Recruiting
Research Team
Z
zixiao Li, PhD
CONTACT
W
WENJIE WANG, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here